Literature DB >> 5044500

Studies for safety of adjuvant 65.

M R Hilleman, A F Woodhour, A Friedman, A H Phelps.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 5044500

Source DB:  PubMed          Journal:  Ann Allergy        ISSN： 0003-4738


× No keyword cloud information.
  6 in total

1.  Recent advances in applied malaria immunology.

Authors:  C A Speer; P H Silverman
Journal:  Z Parasitenkd       Date:  1979-11

2.  Immunity to influenza in ferrets. X. Intranasal immunization of ferrets with inactivated influenza A virus vaccines.

Authors:  C McLaren; C W Potter; R Jennings
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441

3.  Vaccine adjuvants - Current status and prospects on controlled release adjuvancity.

Authors:  S M Sivakumar; Mohammed M Safhi; M Kannadasan; N Sukumaran
Journal:  Saudi Pharm J       Date:  2011-06-25       Impact factor: 4.330

4.  Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression.

Authors:  A Bekierkunst; L Wang; R Toubiana; E Lederer
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

5.  Influence of type of oil and surfactant concentration on the efficacy of emulsified Mycobacterium bovis BCG cell walls to induce tumor regression in guinea pigs.

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

6.  Effects of structural variations in synthetic glycolipids upon mitogenicity for spleen lymphocytes, adjuvancy for humoral immune response and on anti-tumour potential.

Authors:  V N Nigam; J Bonaventure; C Chopra; C A Brailovsky
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.